Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

7.10$ -7.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Evolus Inc (EOLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 248 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EOLS
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	77	–	146	79	152	127	122	183	172	221	203	183	240	214	195	216	209	157	240	215	257	221	211	0.2	178	160	169	168	189	226	234	230	233	213	229	219	226	221	248
Current Assets	–	0.2	–	0.1	0.3	73	50	45	106	94	139	116	95	152	126	108	132	128	78	162	138	179	143	134	0.1	101	84	96	92	112	150	158	150	151	132	145	135	143	139	168
Cash	–	0.2	–	–	–	–	50	44	105	93	54	30	39	110	35	30	85	103	22	132	108	146	107	84	0.1	54	31	42	39	63	97	94	85	87	68	62	44	54	50	45
Cash & Short-Term Investments	–	–	–	–	–	–	50	44	105	93	134	100	74	130	100	85	110	108	22	132	108	146	107	84	0.1	54	31	42	39	63	97	94	85	87	68	62	44	54	50	45
Receivables	–	–	–	–	–	73	73	–	–	–	-2.8	1.4	7.2	11	10	8.6	11	9.7	41	12	13	15	17	21	0.0	22	23	29	30	31	34	43	45	48	47	48	50	55	52	62
Inventory	–	–	–	–	–	–	0.0	0.0	0.0	–	2.6	12	10	6.4	13	10	4.9	3.4	2.8	3.3	3.8	1.8	3.6	12	0.0	19	23	20	18	11	12	13	15	12	10	26	33	27	25	41
Property, Plant & Equipment	–	–	–	–	–	–	0.0	0.0	0.0	–	0.8	5.3	5.2	5.0	5.3	5.2	1.4	4.7	1.2	4.2	1.1	1.4	1.3	1.5	1.9	2.6	2.6	2.4	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	21	–	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21	0.0	21	21	21	21	21	21	21	21	21	21	21	21	21	21	21
Intangible Assets	–	56	–	56	56	56	56	56	56	56	59	59	60	60	59	58	57	55	54	52	51	51	50	49	0.0	49	48	47	47	47	47	46	47	49	49	49	49	48	47	46
Total Liabilities	–	85	–	213	95	228	75	84	88	87	146	162	166	161	152	151	181	282	134	134	118	176	153	164	0.2	159	153	176	187	210	208	214	224	227	220	247	248	249	249	279
Current Liabilities	–	63	–	69	30	213	3.6	3.7	5.5	5.3	9.4	23	26	24	23	19	13	180	88	87	71	58	41	52	0.1	47	41	41	49	48	47	54	61	63	56	64	67	75	68	99
Short-Term Debt	–	60	60	69	29	211	–	–	–	–	0.8	1.0	1.1	1.2	1.2	1.2	1.2	95	21	21	21	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.4	1.4	1.2	1.0	1.6	1.7	2.0	2.4	2.5	2.5	2.6	2.6
Accounts Payable	–	2.9	–	0.5	0.3	0.4	0.5	0.8	0.7	1.6	1.9	7.7	6.1	5.8	11	11	3.0	9.6	13	8.1	7.4	6.1	7.6	10	0.0	8.9	10	7.8	12	4.3	11	10	14	9.2	16	23	23	23	20	44
Long-Term Debt	–	–	–	–	135	–	16	16	17	–	90	90	91	91	92	93	114	41	–	–	–	71	71	72	72	72	72	95	95	120	121	121	121	122	122	145	146	146	156	157
Shareholders' Equity	–	-7.1	-7.1	-67	-16	-76	52	38	95	-123	75	41	17	79	63	44	35	-73	23	106	97	82	67	47	0.0	18	6.9	-7.0	-19	-21	18	19	5.9	5.5	-6.6	-19	-29	-23	-29	-31
Retained Earnings	–	-67	–	-73	-78	-76	-82	-99	-111	-123	-134	-172	-199	-213	-233	-254	-265	-376	-370	-385	-405	-423	-440	-464	-464	-497	-512	-530	-547	-559	-572	-583	-603	-609	-628	-645	-661	-661	-672	-680
Shares Outstanding	17	19	19	19	19	19	20	24	25	27	27	27	27	31	34	34	34	34	41	51	55	56	56	56	56	56	56	57	57	57	59	63	63	63	64	65	65	64	65	66

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings